January 18, 2022
The trials were conducted on 300 patients who were treated at home, and would work on mild to moderate Covid-19 cases.
The trials were conducted on 300 patients who were treated at home, and would work on mild to moderate Covid-19 cases.
January 18, 2022
The trials were conducted on 300 patients who were treated at home, and would work on mild to moderate Covid-19 cases.